As reported for 12A8, following c-kit binding and internalization, radiolabeled 67A2 was metabolized and 125I activity was cleared from the cells, while 111In activity remained, indicating metal radionuclides are suitable for imaging (111In) and therapy (90Y) using 67A2 to target tumor cells. This evidence concerns the gene KIT and neoplasm.